Skip to main content
SpringerLink
Log in

Wechselbeziehungen zwischen Triglyceriden, Fettsäure- und Glucose-Metaboliten

  • Conference paper
Aktuelle Probleme der Pathobiochemie

Part of the book series: Zusammenarbeit von Klinik und Klinischer Chemie ((ZUSAMMENARBEIT))

  • 39 Accesses

Zusammenfassung

über die Beziehungen zwischen Kohlenhydrat- und Fettstoffwechsel und die Reaktionen auf Belastung mit Hormonen, Substraten und Medikamenten haben Versuchsanordnungen an isolierten durchströmten Organen, Fettgewebe und Zellkulturen eine Fülle an Informationen geliefert (Literaturübersicht bei 1–4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. HASSELBLATT, A., F. VON (Hrsg.): Insulin II. Berlin, Heidelberg, New York: Springer 1975

    Google Scholar 

  2. SCHATZ, H.: In: WEITZEL, G. und ZÖLLNER, N. (Hrsg.). Insulin. Biosynthese und Sekretion. Stuttgart: Thieme 1976

    Google Scholar 

  3. LEFEBVRE, P.J., UNGER, R.H. (Eds.): Glukagon. London, New York: Pergamon Press 1972

    Google Scholar 

  4. DUBACH, U.C., BOCKERT, A. (Eds.): Recent hypoglycemic sulfonylureas. Bern, Stuttgart, Vienna: Hans Huber Publishers 1970

    Google Scholar 

  5. SCHÖFFLING, K., KRONENBERG, G., LAUDAHN, G. (Hrsg.): Glisoxepid. Stuttgart: Schattauer 1974

    Google Scholar 

  6. CERASI, E.: Mechanismus of glucose stimulated insulin secretion in health and in diabetes: Some re-evaluations and proposals. Diabetologia 11, 1 (1975)

    Article  PubMed  CAS  Google Scholar 

  7. RANDLE, P,J., GARLAND, P.B., HALES, C.N., NEWSHOLME, E.A.: The glucose fatty-acid cycle. Lancet 1963/I, 785

    Article  Google Scholar 

  8. BALASSE, E.O., NEEF, M.A.: Operation of the “glucose-fatty acid cycle” during experimental elevations of plasma free fatty acid levels in man. Europ. J. Clin. Invest. 4, 247 (1974)

    PubMed  CAS  Google Scholar 

  9. EGGSTEIN, M., KREUTZ, F.H.: Über Wechselbeziehungen zwischen Blutfetten und Glucosemetaboliten. Verh. dtsch. Ges. Inn. Med. 67, 702 (1961)

    Google Scholar 

  10. EGGSTEIN, M.: Zur Regulation des Serumneutralfettes und seiner Spaltprodukte und von Glucose, Lactat und Pyruvat im Blut. Verh. dtsch. Ges. Inn. Med. 71, 476 (1965)

    CAS  Google Scholar 

  11. BERG, G., MATZKIES, F.: Serumlipoproteide und Ketonkörper nach intravenöser Dauerinfusion von Sorbit. Klin. Wschr. 53, 187 (1975)

    Article  PubMed  CAS  Google Scholar 

  12. BERG, G., MATZKIES, F.: Stoffwechselwirkungen einer Kohlenhydratkombinationslösung (Glucose, Fructose, Xylit 2:2:1) bei parenteraler Ernährung. Dtsch. med. Wschr. 101, 369 (1976)

    CAS  Google Scholar 

  13. EGGSTEIN, M., KNODEL, W., KREMER, H., BAETZNER, P.: Substrat-und Metabolitverschiebungen im Blut nach Adrenalin und ß-Rezeptorenblockern. Klin. Wschr. 45, 943 (1967)

    Article  CAS  Google Scholar 

  14. HIMMS-HAGEN, J.: Effects of catecholamines on metabolism. In: BLASCHKO, H. and MUSCHOLL, E. (Eds.). Catecholamines. Handb. Exp. Pharm. Vol. 33. Berlin, Heidelberg, New York: Springer 1972

    Google Scholar 

  15. BURR, I.M., SLONIM, A.E., SHARP, R.: Interactions of acetylcholine and epinephrine on the dynamics of insulin release in vitro. J. Clin. Invest. 58, 230 (1976)

    Article  PubMed  CAS  Google Scholar 

  16. TURNER, R.C., HART, G., LONDON, D.R.: Suppression of basal insulin secretion by adrenalin in normal man and in patients with insulinomas. Diabetologia 13, 19 (1977)

    Article  PubMed  CAS  Google Scholar 

  17. GREENE, M.D.: Effect of epinephrine on lactate, pyruvate and excess lactate production in normal human subjects. J. Lab. Clin. Med. 58, 682 (1961)

    PubMed  CAS  Google Scholar 

  18. WILLIAMSON, J.R.: Metabolic effects of epinephrine in the isolated perfused rat heart. J. Biol. Chem. 239, 2721 (1964)

    PubMed  CAS  Google Scholar 

  19. DAVIS, E.A.: The effects of insulin and adrenalin on the metabolism of glucose and lactate by perfused guinea pig hearts. Can. J. Biochem. 43, 1001 (1965)

    Article  PubMed  CAS  Google Scholar 

  20. GRIES, F.A., BERGER, M., OBERDISSE, K.: Untersuchungen zum antilipolytischen Effekt des Insulins am menschlichen Fettgewebe in vitro. Diabetologia 4, 262 (1968)

    Article  PubMed  CAS  Google Scholar 

  21. ZAPF, J., FEUERLEIN, D., WALDVOGEL, M., FROESCH, E.R.: Increased sensitivity of diabetic rat adipose tissue towards the lipolytic action of epinephrine. Diabetologia 11, 509 (1975)

    Article  PubMed  CAS  Google Scholar 

  22. MULLER, W.A., AOKI, T.T., EGDAHL, R.H., CAHILL, G.F.Jr.: Effects of exogenous glucagon and epinephrine in physiological amounts on the blood levels of free fatty acids and glycerol in dogs. Diabetologia 13, 55 (1977)

    Article  PubMed  CAS  Google Scholar 

  23. ROBERTSON, R.P., HALTER, J.B., PORTE, D.Jr.: A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus. J. Clin. Invest. 57, 791 (1976)

    Article  PubMed  CAS  Google Scholar 

  24. BACHMANN, G.W.: Beta-Sympathicolyse als therapeutisches Prinzip. Kurzmonographie 7. Nürnberg: Sandoz AG 1972

    Google Scholar 

  25. BURNS, T.W., MOHS, J.M., LANGLEY, P.E., YAWN, R., CHASE, G.R.: Regulation of human lipolysis. J. Clin. Invest. 53, 338 (1974)

    Article  PubMed  CAS  Google Scholar 

  26. KOIVISTO, V.V.A., NIKKILA’, E.A., AKERBLOM, H.K.: Influence of norepinephrine and exercise on lipolysis in adipose tissue of diabetic rats. Diabetologia 11, 401 (1975)

    Article  PubMed  CAS  Google Scholar 

  27. SCHADE, D.S., EATON, R.P.: Modulation of fatty acid metabolism by glucagon in man. III. Diabetes 24, 1020 (1975)

    Article  PubMed  CAS  Google Scholar 

  28. SCHADE, D.S., EATON, R.P.: Modulation of fatty acid metabolism by glucagon in man. II. Diabetes 24, 510 (1975)

    Article  PubMed  CAS  Google Scholar 

  29. DIETZE, G., WICKLMAYR, M., HEPP, K.D., BOGNER, W., MEHNERT, H., CZEMPIEL, H., HENFTLING, H.G.: On gluconeogenesis of human liver. Diabetologia 12, 555 (1976)

    Article  PubMed  CAS  Google Scholar 

  30. SPECTOR, A.A.: Fatty acid binding to plasma albumin. J. Lipid. Res. 16, 165 (1975)

    PubMed  CAS  Google Scholar 

  31. EGGSTEIN, M.: Probleme der Fett-und Kohlenhydratstoffwechselüberwachung von Schwerkranken bei partieller und totaler parenteraler Ernährung. Verh. dtsch. Ges. Inn. Med. 74, 321 (1968)

    PubMed  CAS  Google Scholar 

  32. GREY, N.J., KARL, I., KIPNIS, D.M.: Physiologic mechanisms in the development of starvation ketosis in man. Diabetes 24, 10 (1975)

    Article  PubMed  CAS  Google Scholar 

  33. SIIERWIN, R.S., FISHER, M., HENDLER, R., FELIG, P.: Hyperglucagonemia and blood glucose regulation in normal obese and diabetic subjects. New Engl. J. Med. 294, 455 (1976)

    Google Scholar 

  34. RECANT, L., ALP, H., KOCH, M., EGGEMAN, J.: Non-esterifiedfatty-acid releasing mechanism in diabetic serum. Lancet 1963/II, 614

    Article  Google Scholar 

  35. VANGBAU, M., BERGER, J.E., STEINBERG, D.: Hormone sensitive lipase und monoglyceride lipase activities in adipose tissue. J. Biol. Chem. 239, 401 (1964)

    Google Scholar 

  36. LÖFFLER, G., GEERLING, H., WEINGES, K.F.: Der Glukosestoffwechsel des isolierten Fettgewebes bei Lipogenese und Lipolyse. Verh. dtsch. Ges. Inn. Med. 71, 470 (1965)

    Google Scholar 

  37. SCHADE, D.S., EATON, R.P.: Modulation of fatty acid metabolism by glucagon in man. I. Diabetes 24. 502 (1975)

    Article  CAS  Google Scholar 

  38. EATON, R.P.: Evolving role of glucagon in human diabetes mellitus. Diabetes 24, 523 (1975)

    PubMed  CAS  Google Scholar 

  39. SAMOLS, E., MARRI, G., MARKS, V.: Promotion of insulin secretion by glucagon. Lancet 1965/II, 415

    Article  Google Scholar 

  40. SAMOLS, E., MARRI, G., MARKS, V.: Interrelationship of glucagon, insulin and glucose. Diabetes 15, 855 (1966)

    PubMed  CAS  Google Scholar 

  41. SCHADE, D.S., EATON, R.P.: The contribution of endogenous insulin secretion to the ketogenic response to glucagon in man. Diabetologia 11, 555 (1975)

    Article  PubMed  CAS  Google Scholar 

  42. LILJENQUIST, J.E., BOMBOY, J.D., LEWIS, S.B., SINCLAIRSMITH, B.C., FELTS, P,W., LACY, W.W., CROFFORD, B.O., LIDDLE, G.W.: Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men. J. Clin. Invest. 53, 190 (1974)

    Article  PubMed  CAS  Google Scholar 

  43. GARBER, A.J, CRYER, P.E., SANTIAGO, J.V., HAYMOND, M.W., PAGLIARA, A.S., KIPNIS, D.M.: The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Invest. 58, 7 (1976)

    Article  PubMed  CAS  Google Scholar 

  44. ÖSTMAN, J., BACKMAN, L., HALLBERG, D.: Cell size and the antilipolytic effect of insulin in human subcutaneous adipose tissue. Diabetologia 11, 159 (1975)

    Article  PubMed  Google Scholar 

  45. GANDA, O.P., KAHN, C.B., SOELDNER, J.S., GLEASON, R.E.: Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects. Diabetes 24, 354 (1975)

    Article  PubMed  CAS  Google Scholar 

  46. BAUMEISTER, G., WAGNER, H., STAHL, M.: Klinisch experimentelle Untersuchungen zur Beeinflussung der pankreatischen Glukagoninkretion durch Tolbutamid und Glibenclamid. Klin. Wschr. 53, 571 (1975)

    Article  PubMed  CAS  Google Scholar 

  47. BITTNER, R., BEGER, H.G., KRASS, E., ROSCHER, R.: Glucoseverwertung und Dynamik der Insulinsekretion. Messungen nach intraabdominellen Operationen. Klin. Wschr. 53, 861 (1975)

    Article  PubMed  CAS  Google Scholar 

  48. BLACKARD, W.G., NELSON, N.C.: Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes 19, 302 (1970)

    PubMed  CAS  Google Scholar 

  49. KARAKASH, C., ASSIMACOPOULOS-JEANNET, F., JEANRENAUD, B.: An anomaly of insulin removal in perfused livers of obese-hyperglycemic (ob/ob) mice. J. Clin. Invest. 57, 1117 (1976)

    Article  PubMed  CAS  Google Scholar 

  50. TERRIS, S., STEINER, D.F.: Retention and degration of 1251-insulin by perfused livers from diabetic rats. J. Clin. Invest. 57, 885 (1976)

    Article  PubMed  CAS  Google Scholar 

  51. SIREK, O.V., SIREK, A., POLICOVA, Z.: Inhibition of sulphonylurea-stimulated insulin secretion by beta adrenergic blockade. Diabetologia 11, 269 (1975)

    Article  PubMed  CAS  Google Scholar 

  52. KRAAS, E., BITTNER, R., MEVES, M., BEGER, H.G.: Insulinkonzentrationen im Pfortaderblut des Menschen nach Glucose-Infusion. Klin. Wschr. 52, 404 (1974)

    Article  PubMed  CAS  Google Scholar 

  53. BITTNER, R., BEGER, H.G., KRAAS, E.: Profil der glucosestimulierten Insulinsekretion im Pfortaderblut des Menschen. Klin. Wschr. 52, 575 (1974)

    Article  PubMed  CAS  Google Scholar 

  54. JOHNSTON, D.G., ALBERTI, K.G.M.M., FABER, O.K., BINDER, C., WRIGHT, R.: Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion? Lancet 1977/I, 10

    Article  Google Scholar 

  55. GEISELER, D., SCHMÜLLING, R.M., EGGSTEIN, M.: Ein systemtheoretisches Modell zum Verständnis der unterschiedlichen Glykolyseaktivierung nach intravenöser Insulin-bzw. Tolbutamidverabreichung. 12. Jahrestagung Deutsche Diabetes-Gesellschaft Homburg/Saar Mai 1977. NOVO-Information, Vortrag 17a (1977)

    Google Scholar 

  56. MULLER, W.A., FALOONA, G.R., UNGER, R.H.: The influence of the antecedent diet upon glucagon and insulin secretion. New Engl. J. Med. 285, 1450 (1971)

    CAS  Google Scholar 

  57. MACKRELL, D.J., SOKAL, J.E.: Antagonism between the effects of insulin and glucagon on the isolated liver. Diabetes 18, 724 (1969)

    PubMed  CAS  Google Scholar 

  58. PARRILLA, R., GOODMAN, M.N., TOEWS, C.J.: Effect of glucagon: Insulin ratios on hepatic metabolism. Diabetes 23, 725 (1974)

    PubMed  CAS  Google Scholar 

  59. GERICH, J.E., LORENZI, M., BIER, D.M., SCHNEIDER, V., TSALIKIAN, E., KARAM, J.H., FORSHAM, P.H.: Prevention of human diabetic ketoacidosis by somatostatin. New Engl. J. Med. 292, 985 (1975)

    CAS  Google Scholar 

  60. ALBERTI, K.G.M.M., CHRISTENSEN, N.J., IVERSEN, J., ORSKOV, H.: Role of glucagon and other hormones in development of diabetic ketoacidosis. Lancet 1975/I, 1307

    Google Scholar 

  61. GERICH, J.E., LORENZI, M., BIER, D.M., TSALIKIAN, E., SCHNEIDER, V., KARAM, J.H., FORSHAM, P.H.: Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. J. Clin. Invest. 57, 875 (1976)

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. R.-M. Schmülling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Geiseler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Eggstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Biochemische Forschung E. Merck, Darmstadt, Deutschland

    Hermann Lang

  2. Institut für Klinische Chemie und Laboratoriumsdiagnostik der Universität Düsseldorf, Deutschland

    Wirnt Rick

  3. Institut für Klinische Chemie an den Universitätskliniken Gießen, Deutschland

    Ladislaus Róka

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Schmülling, RM., Geiseler, D., Eggstein, M. (1978). Wechselbeziehungen zwischen Triglyceriden, Fettsäure- und Glucose-Metaboliten. In: Lang, H., Rick, W., Róka, L. (eds) Aktuelle Probleme der Pathobiochemie. Zusammenarbeit von Klinik und Klinischer Chemie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81227-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81227-9_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-08688-8

  • Online ISBN: 978-3-642-81227-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation